The goal of the Developmental Research Program is to identify and support high quality, conceptually innovative translational projects that are not yet mature for full program status despite having outstanding potential. The Developmental Research Program will facilitate the attainment of this objective by 1) coordinating developmental research project selection 2) fostering the success of these projects through monitoring of their progress and 3) establishing institutional and extramural collaborations. Moreover, at the discretion of the Executive Committee of the SPORE, pilot projects which generate promising results can replace SPORE research projects which become funded as independent R01 or POI's projects and replace research projects which fail to show satisfactory progress. The long term goal of the Lymphoma SPORE program is to translate the findings generated by the Developmental Projects into a reduction of the incidence, morbidity and mortality of lymphoma. Specifically, the Developmental Research Program will; 1. Encourage innovative laboratory, population, and clinical studies with translational relevance by providing seed money to investigators 2. Support the evolution of developmental projects by providing intellectual and practical feedback through critical review and monitoring 3. Encourage intra-institutional and extramural collaborations between basic, clinical and population sciences with impact on translational research in lymphoma 4. Contribute to the overall success of the SPORE by providing the Executive Committee with guidance regarding promising projects in City of Hope's lymphoma translational research pipeline

Public Health Relevance

The goal of the Developmental Research Program is to identify and support high quality, conceptually innovative translational projects that are not yet mature for full program status despite having outstanding potential.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA107399-08
Application #
8566757
Study Section
Special Emphasis Panel (ZCA1-GRB-I)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
8
Fiscal Year
2013
Total Cost
$35,406
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Jonnalagadda, Mahesh; Mardiros, Armen; Urak, Ryan et al. (2015) Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy. Mol Ther 23:757-68
Lacoste, Sandrine; Bhatia, Ravi; Bhatia, Smita et al. (2014) Granulocytes affect double-strand break repair assays in primary human lymphocytes. PLoS One 9:e93185
Herrmann, Andreas; Priceman, Saul J; Swiderski, Piotr et al. (2014) CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells. J Clin Invest 124:2977-87
Chadalavada, Deepti; Adamson, Trinka W; Burnett, John C et al. (2014) Irradiated compared with nonirradiated NSG mice for the development of a human B-cell lymphoma model. Comp Med 64:179-85
Yang, Chunmei; Lee, Heehyoung; Pal, Sumanta et al. (2013) B cells promote tumor progression via STAT3 regulated-angiogenesis. PLoS One 8:e64159
Xin, Hong; Lu, Rongze; Lee, Heehyoung et al. (2013) G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells. J Biol Chem 288:13842-9
Zhou, Jiehua; Tiemann, Katrin; Chomchan, Pritsana et al. (2013) Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. Nucleic Acids Res 41:4266-83
Ng, Thomas S C; Wert, David; Sohi, Hargun et al. (2013) Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101. Clin Cancer Res 19:2518-27
Jonnalagadda, M; Brown, C E; Chang, W C et al. (2013) Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase. Gene Ther 20:853-60
Yang, Chunmei; Lee, Heehyoung; Jove, Veronica et al. (2013) Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer. PLoS One 8:e54029

Showing the most recent 10 out of 59 publications